stockportfolio.pro
Stocks / ARWR vs EHC
ARWR vs EHC
Arrowhead Pharmaceuticals, Inc. and Encompass Health Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Arrowhead Pharmaceuticals, Inc. (ARWR) | Encompass Health Corporation (EHC) | |
|---|---|---|
| Market cap | $10.0B | $10.1B |
| Revenue (latest FY) | $829.45M | $5.94B |
| Net income (latest FY) | $-1.63M | $566.20M |
| Revenue growth (5y CAGR) | 56.6% | 10.7% |
| Net margin | -0.2% | 9.5% |
| Return on equity | -0.3% | 23.2% |
| P/E ratio | — | 17.5 |
| Dividend yield | — | 0.7% |
| Profitable years (of last 10) | 1 | 10 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ARWR — free Open EHC — freeFrequently asked questions
Which is bigger, ARWR or EHC?
Encompass Health Corporation is larger by market capitalization — $10.1B versus $10.0B.
Which grows faster, ARWR or EHC?
Over the last five fiscal years, Arrowhead Pharmaceuticals, Inc. grew revenue faster — 56.6%/yr versus 10.7%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.